Follow the Cipher Pharmaceuticals Inc. share price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are quoted on CA CA, under the authority of SEDI. Market capitalisation: €256.5m. The latest transaction was disclosed on 25 June 2026 (57 - Exercise of rights). Among the most active insiders: Mull, Craig. The full history is openly available.
26
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
28Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,480 of 28,017 companies
75.0
score / 100
Value
58
Quality
92
FCF yld6.9%
Earn yld6.4%
EV/EBITDA18.0x
ROE26%
Gross mgn80%
Net mgn54%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
30,000 shares@ CA$14.53100.0% of flowOptionsTSXSEDI:4730245
25 of 26 declarations
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. is a Canadian company focused on the development and commercialization of pharmaceutical products. It specializes in treatments for dermatological diseases and other medical conditions.